Sponsor
The University of Texas Health Science Center, Houston
Status
Recruiting
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT04920097
The proposed randomized control trial will evaluate auricular point acupressure (APA) on chemotherapy-induced neuropathy (CIN), rigorously considering point specificity and placebo effects by integrating self-report measures, psychophysical measures (QST), endogenous biomarkers (cytokines), and neuro-imaging to investigate APA's efficacy and underlying mechanism(s).
The investigators will use a randomized control trial, three-group design: (1) APA Group, (2) Sham APA Control, and (3) Usual Care Control. A smartphone application for ecological momentary assessment (EMA) will be used to monitor APA adherence and capture momentary CIN severity and analgesic use.
The investigators will use a randomized control trial, three-group design: (1) APA Group, (2) Sham APA Control, and (3) Usual Care Control. A smartphone application for ecological momentary assessment (EMA) will be used to monitor APA adherence and capture momentary CIN severity and analgesic use.
Intervention
Virtual Auricular Point Acupressure (APA), In-Person Training, Usual Care
Condition
Chemotherapy-induced Neuropathy
Investigators
Constance Johnson, PhD, MS, RN, Constance H Johnson, PhD, MS, RN